FMP
Evofem Biosciences, Inc.
EVFM
PNK
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
0.015 USD
-0.0009 (-6%)
About
ceo
Ms. Saundra Pelletier
sector
Healthcare
industry
Biotechnology
website
https://www.evofem.com
exchange
PNK
Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
CIK
0001618835
ISIN
US30048L3024
CUSIP
30048L104
Address
12400 High Bluff Drive
Phone
858 550 1900
Country
US
Employee
35
IPO Date
Nov 20, 2014
Key Executives
